Global Medical Radioisotopes Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Medical Radioisotopes market size was valued at US$ 699 million in 2024 and is forecast to a readjusted size of USD 930 million by 2031 with a CAGR of 4.2% during review period.

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person"s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.

Global key medical radioisotopes manufacturers include NRG, IRE etc.The top 2 companies hold a share about 40%.Americas is the largest market, with a share about 45%, followed by Europe and APAC with the share about 25% and 23%.

This report is a detailed and comprehensive analysis for global Medical Radioisotopes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Medical Radioisotopes market size and forecasts, in consumption value ($ Million), 2020-2031

Global Medical Radioisotopes market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Medical Radioisotopes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Medical Radioisotopes market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Medical Radioisotopes

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Medical Radioisotopes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen, Polatom, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Medical Radioisotopes market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes

Market segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others

Market segment by players, this report covers
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Medical Radioisotopes product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Medical Radioisotopes, with revenue, gross margin, and global market share of Medical Radioisotopes from 2020 to 2025.

Chapter 3, the Medical Radioisotopes competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Medical Radioisotopes market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Radioisotopes.

Chapter 13, to describe Medical Radioisotopes research findings and conclusion.